Related Experiment Video
Updated: Sep 24, 2025
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
623
Progress in Radiotherapy for Cholangiocarcinoma.
Ningyu Wang1, Ai Huang1, Bohua Kuang1
1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in Oncology
|May 6, 2022
Summary
Radiotherapy is crucial for treating advanced cholangiocarcinoma (CCA) when surgery isn't an option. This review explores optimal radiotherapy strategies, including advanced techniques and combined therapies, for better CCA patient outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Gastroenterology
Background:
- Cholangiocarcinoma (CCA) is a highly malignant bile duct cancer with a poor prognosis.
- Radical resection offers the only cure, but most patients present with advanced disease, precluding surgery.
- Radiotherapy is vital for neoadjuvant, adjuvant, and palliative care in locally advanced CCA.
Purpose of the Study:
- To review current clinical studies on radiotherapy for cholangiocarcinoma (CCA).
- To discuss optimal timing, target delineation, and dosage for CCA radiotherapy.
- To summarize advanced radiotherapy techniques and novel combination therapies for CCA.
Main Methods:
- Review of recent clinical studies on cholangiocarcinoma (CCA) radiotherapy.
- Analysis of large fraction radiotherapy techniques, including stereotactic body radiotherapy (SBRT) and proton therapy.
- Examination of immunotherapy and targeted drug combinations with radiotherapy for CCA.
Main Results:
- Current recommendations for CCA radiotherapy timing, target delineation, and dosage lack uniformity.
- Advanced techniques like SBRT and proton therapy show promise in CCA treatment.
- Combining radiotherapy with immunotherapy and targeted drugs is an emerging area for CCA management.
Conclusions:
- Standardized guidelines for CCA radiotherapy are needed.
- Advanced radiotherapy techniques and multimodal approaches, including immunotherapy and targeted therapy, represent the future of CCA treatment.
- Further research is essential to optimize radiotherapy protocols and combination strategies for improved cholangiocarcinoma outcomes.
